JAMP-BRIMONIDINE
JAMP-BRIMONIDINE
Approved
DIN Number
02449226
Drug Class
Human
Market Date
Apr 11, 2023
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02449226
AIG Number0131859001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EA05 BRIMONIDINE
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:40.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
BRIMONIDINE TARTRATEActive
Strength: 0.2 % / W/V
Monograph: BRIMONIDINE TARTRATE